Health Concerns

Blood Testing Protocols

References

ADVANCEDATA. Vital & Health Statistics/The National Center for Health Statistics/U.S. Department of Health, Education and Welfare/Public Health Service. 1977. Atlanta, GA: Centers for Disease Control. Available at: http://www.cdc.gov/nchs/data/ad/ad007acc.pdf. Accessed July 2006.

American Family Physician: Goals for Lowering Your Cholesterol. Leawood, KS: American Academy of Family Physicians; 2001. Available at: http://www.findarticles.com/p/articles/mi_m3225/is_2_63/ai_68974579. Accessed July 2006.

Barrett-Connor E, Von Muhlen DG et al. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo Study. J Clin Endocrinol Metab. 1999 Feb;84(2):573–7.

Dayan CM, Saravanan P et al. Whose normal thyroid function is better—yours or mine? Lancet. 2002 Aug 3;360(9330):353.

Gelfand MM, Wiita B. Androgen and estrogen-androgen hormone replacement therapy: A review of the safety literature, 1941 to 1996. Clin Ther. 1997 May;19(3):383–404.

Gooren LJ. Endocrine aspects of ageing in the male. Mol Cell Endocrinol. 1998 Oct 25;145(1-2):153–9.

Hak AE, Pols HA et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study. Ann Intern Med. 2000 Feb 15;132(4):270–8.

Hansson L, Zanchetti A et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998 Jun 13;351(9118):1755–62.

Janowsky JS, Chavez B et al. Sex steroids modify working memory. J Cogn Neurosci. 2000 May;12(3):407–14.

Lazarou J, Pomeranz BH et al. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998 Apr 15;279(15):1200–5.

Michalopoulou G, Alevizaki M et al. High serum cholesterol levels in persons with ‘high-normal’ TSH levels: Should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol. 1998 Feb;138(2):141–5.

Phillips GB, Pinkernell BH et al. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994 May;14(5):701–6.

Pollock MA, Sturrock A et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: Randomised double blind placebo controlled crossover trial. BMJ. 2001 Oct 20;323(7318):891–5.

Rabkin JG, Wagner GJ et al. Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol. 1999 Feb;19(1):19–27.

Schweiger U, Deuschle M et al. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosom Med. 1999 May;61(3):292–6.

Seidman SN, Walsh BT. Testosterone and depression in aging men. Am J Geriatr Psychiatry. 1999;7(1):18–33.

Shackman J. Super T. New York: Simon & Schuster/Fireside; 1999:43–4.

Shippen E. The Testosterone Syndrome. New York: M. Evans; 2001:116.

Tan RS, Pu SJ. The andropause and memory loss: Is there a link between androgen decline and dementia in the aging male? Asian J Androl. 2001 Sep;3(3):169–74.

Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 1992 Oct;75(4):1092–8.

Vanderpump MP, Tunbridge WM et al. The incidence of thyroid disorders in the community: A twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55–68.

Wright JV. Maximize Your Vitality & Potency. Petaluma, CA: Smart Publications; 1999:146–7.